Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
efavirenz (sustiva) (1 trial)
raltegravir (isentress) (1 trial)
Hepatitis (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Trials (1 total)
Trial APIs (2 total)